Lars Plate

A recent study from the labs of Lars Plate and Jens Meiler, published in the Proceedings of the National Academy of Sciences of the United States of America, analyzed both selectively responsive and poorly responsive variants of cystic fibrosis and revealed the molecular determinants of drug response. Read More

Eleven outstanding faculty members from across the university have been selected for the 2025 cohort of Chancellor Faculty Fellows. Each fellow holds the title of Chancellor Faculty Fellow and receives $80,000 over a multi-year period to support their work. Read More

Lars Plate, assistant professor of chemistry and biological sciences, has received a $2.76 million collaborative grant to investigate medical therapy for people with cystic fibrosis. The interdisciplinary project brings together teams with varied expertise in computational structural biology, proteomics, biophysics, and physiology in hopes of improving the quality of life for those afflicted with the genetic disease. Read More

The 2023 annual Vanderbilt Institute of Chemical Biology Symposium, featuring prominent scientists—including keynote speaker Dr. John Yates III—will be Aug. 8 at the Student Life Center. Sponsored by Ancora Innovation, the event will include discussions on innovative life science research and drug development, promising a day of knowledge sharing and networking for Vanderbilt students, staff and faculty. Read More

For his work on zoonotic threat mitigation, Lars Plate was awarded $50,000 from the Research Corporation for Science Advancement and the U.S. Department of Agriculture. Read More

Lars Plate wins $55,000 from Scialog to further collaborative research on cell behavior. Read More

When Mason Clark was in middle school, his beloved grandmother suffered a serious heart attack. She survived, thanks to the help of the local hospital, and the experience led Clark to his life’s purpose. Read More

Molecule 147 neutralizes 95 percent of Dengue and Zika viruses, a promising direction for host-directed treatments and combination therapy. Read More

Understanding the function of host cells when infected with SARS-CoV-2 may lead to host-directed antiviral therapeutics. Read More